{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:18:48Z","timestamp":1793146728485,"version":"4.5.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Stevens-Johnson syndrome and toxic epidermal necrolysis represents a life-threatening disease spectrum that occurs primarily as a medication reaction. While antibiotics, allopurinol, and anticonvulsants are among the most commonly implicated medications, case reports exist showing antihypertensive medications as a less-recognized culprit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic review of literature identified cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from antihypertensive medications, and we compiled a comprehensive description of offending medications and the subsequent clinical course.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>There were 34 studies that met inclusion criteria, with 1 study being a case series of 3 cases, for a total of 36 cases. Patients had a median age of 65-years-old, are predominantly females, and present to the hospital at a median of 11 days after initiation of the medication. Symptoms at presentation are primarily rash with fever\/chills, oral\/mucosal lesions, and malaise also being frequently seen. Diltiazem was the most frequently implicated medication, followed by minoxidil and captopril, while calcium channel blockers were the most frequently implicated antihypertensive class, followed by diuretics and vasodilators. Diagnosis was obtained primarily through biopsy or clinically. Treatment consisted of discontinuation of the offending drug in all cases, as well as systemic corticosteroids in over half of cases. Patients were hospitalized for a median of 10 days, with complications including sepsis, renal failure, and cardiopulmonary arrest. Ultimately, complete resolution and discharge occurred in 74% of cases, with death in 26%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Early recognition by clinicians is vital to achieving a favorable outcome, but identification of culprit medications can be difficult. Future studies should seek larger sample sizes and try to prove causation by further understanding the underlying pathophysiology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000045350","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:00:08Z","timestamp":1762210808000},"page":"e45350","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Stevens-Johnson syndrome or toxic epidermal necrolysis from antihypertensive medications: A systematic review of cases"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2106-5897","authenticated-orcid":false,"given":"Rebecca M.","family":"Gibons","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences, Florida State University College of Medicine, Tallahassee, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Behers","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Florida State University Internal Medicine Residency at Sarasota Memorial Hospital, Sarasota, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sanchez","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Nova Southeastern University College of Osteopathic Medicine, Hollywood, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Melchor","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Duke University Family Medicine Residency, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Riveros","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Florida State University Internal Medicine Residency at Sarasota Memorial Hospital, Sarasota, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia F.","family":"Moretta","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Florida State University College of Medicine, Tallahassee, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole G.","family":"Bentze","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Florida State University College of Medicine, Tallahassee, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4062\/biomolther.2023.170","article-title":"Immunological mechanisms in cutaneous adverse drug reactions.","volume":"32","author":"Lee","year":"2024","journal-title":"Biomol Ther (Seoul)"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3390\/jcm14030857","article-title":"Drug-induced serious cutaneous reactions in hospitalized patients: a cross-sectional study.","volume":"14","author":"Jiamsathit","year":"2025","journal-title":"J Clin Med"},{"key":"R4-20260915","first-page":"1","article-title":"Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a ten-year retrospective study of 103 cases.","author":"Zhou","year":"2025","journal-title":"Clin Exp Dermatol"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R8-20260915","first-page":"e1230","article-title":"PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis.","volume":"18","author":"Haddaway","year":"2022","journal-title":"Campbell Syst Rev"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1345\/aph.1C284","article-title":"Possible captopril-induced toxic epidermal necrolysis.","volume":"37","author":"Alkurtass","year":"2003","journal-title":"Ann Pharmacother"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1097\/BCR.0b013e31822ac7be","article-title":"Amlodipine-induced toxic epidermal necrolysis.","volume":"32","author":"Baetz","year":"2011","journal-title":"J Burn Care Res"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/S0735-1097(23)03133-9","article-title":"Metoprolol induced Steven Johnson syndrome complicated by Kounis syndrome.","volume":"81","author":"Beshai","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/joneph\/20.1.91","article-title":"Stevens-Johnson syndrome associated with oral minoxidil: a case report.","volume":"20","author":"Callen","year":"2007","journal-title":"J Nephrol"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/BF02048370","article-title":"Toxic epidermal necrolysis--an unusual cause of colonic perforation. Report of a case.","volume":"36","author":"Carter","year":"1993","journal-title":"Dis Colon Rectum"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/jcpt.12141","article-title":"Hydralazine-induced toxic epidermal necrolysis in a patient on continuous ambulatory peritoneal dialysis.","volume":"39","author":"Chan","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"R15-20260915","first-page":"72","article-title":"Frusemide induced toxic epidermal necrolysis (TEN) in a 53-year- old Caucasian female.","volume":"64","author":"Datwani","year":"2023","journal-title":"Australas J Dermatol"},{"key":"R16-20260915","first-page":"WD01","article-title":"Carvedilol induced toxic epidermal necrolysis: a rare case report.","volume":"15","author":"Dhande","year":"2021","journal-title":"J Clin Diagn Res"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/archinte.1981.00340120123025","article-title":"Minoxidil-induced Stevens-Johnson syndrome.","volume":"141","author":"DiSantis","year":"1981","journal-title":"Arch Intern Med"},{"key":"R18-20260915","first-page":"1300","article-title":"Life-threatening hypersensitivity reaction to ACE inhibitor used in scleroderma renal crisis. A case report.","volume":"42","author":"Gill","year":"2015","journal-title":"J Rheumatol"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"672","DOI":"10.5694\/j.1326-5377.1992.tb121499.x","article-title":"Stevens\u2013Johnson syndrome induced by verapamil.","volume":"156","author":"Gonski","year":"1992","journal-title":"Med J Aust"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/009286158602000418","article-title":"Evaluation of a case of Stevens-Johnson syndrome.","volume":"20","author":"Jones","year":"1986","journal-title":"Drug Inf J"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1016\/S0735-1097(23)03880-9","article-title":"Chlorthalidone induced Stevens-Johnson syndrome and toxic epidermal necrolysis overlap.","volume":"81","author":"Kaphle","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1592\/phco.29.4.460","article-title":"Fatal toxic epidermal necrolysis associated with minoxidil.","volume":"29","author":"Karaoui","year":"2009","journal-title":"Pharmacotherapy"},{"key":"R23-20260915","first-page":"243","article-title":"Sodium nitroprusside and toxic epidermal necrolysis.","volume":"30","author":"Kilic","year":"2012","journal-title":"Asian Pac J Allergy Immunol"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0002-9149(97)00449-9","article-title":"Stevens-Johnson syndrome associated with carvedilol therapy.","volume":"80","author":"Kowalski","year":"1997","journal-title":"Am J Cardiol"},{"key":"R25-20260915","first-page":"FD01","article-title":"Metolazone associated Stevens Johnson syndrome-toxic epidermal necrolysis overlap.","volume":"10","author":"Kumar","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"R26-20260915","first-page":"1","article-title":"Steven Johnson syndrome: three cases reported in Iraq.","volume":"4","author":"Kurmanji","year":"2012","journal-title":"Int J Pharm Pharm Sci"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1177\/106002808902301207","article-title":"Verapamil-associated Stevens-Johnson syndrome.","volume":"23","author":"Lin","year":"1989","journal-title":"DICP"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"135","DOI":"10.12659\/AJCR.890038","article-title":"A case report of hydralazine-induced skin reaction: probable toxic epidermal necrolysis (TEN).","volume":"15","author":"Mahfouz","year":"2014","journal-title":"Am J Case Rep"},{"key":"R29-20260915","first-page":"797","article-title":"Propranolol induced Steven-Johnson syndrome.","volume":"37","author":"Mukul","year":"1989","journal-title":"J Assoc Physicians India"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-4362.2003.01838.x","article-title":"Stevens\u2013Johnson syndrome associated with ramipril.","volume":"42","author":"Oskay","year":"2003","journal-title":"Int J Dermatol"},{"key":"R31-20260915","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archderm.1993.01680270137028","article-title":"Toxic epidermal necrolysis due to indapamide.","volume":"129","author":"Partanen","year":"1993","journal-title":"Arch Dermatol"},{"key":"R32-20260915","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(84)91807-5","article-title":"Fatal Stevens-Johnson syndrome in a patient on captopril and allopurinol.","volume":"1","author":"Pennell","year":"1984","journal-title":"Lancet"},{"key":"R33-20260915","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/0140-6736(93)91264-M","article-title":"Erythema multiforme, Stevens-Johnson syndrome, and diltiazem.","volume":"341","author":"Sanders","year":"1993","journal-title":"Lancet"},{"key":"R34-20260915","first-page":"200","article-title":"Indapamide-associated Stevens-Johnson syndrome.","volume":"50","author":"Spinler","year":"1992","journal-title":"Cutis"},{"key":"R35-20260915","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/archinte.1989.00390040057011","article-title":"Cutaneous adverse reactions associated with calcium channel blockers.","volume":"149","author":"Stern","year":"1989","journal-title":"Arch Intern Med"},{"key":"R36-20260915","first-page":"948","article-title":"Stevens-Johnson syndrome associated with diltiazem.","volume":"9","author":"Taylor","year":"1990","journal-title":"Clin Pharm"},{"key":"R37-20260915","doi-asserted-by":"crossref","first-page":"549","DOI":"10.5414\/CPP48549","article-title":"Toxic epidermal necrolysis associated with carvedilol treatment.","volume":"48","author":"Vlahovic-Palcevski","year":"2010","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R38-20260915","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/bmj.296.6628.1071-b","article-title":"Severe toxic erythema caused by diltiazem.","volume":"296","author":"Wakeel","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R39-20260915","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archderm.142.7.938","article-title":"Toxic epidermal necrolysis caused by alfuzosin, an alpha1-adrenoceptor antagonist.","volume":"142","author":"Wang","year":"2006","journal-title":"Arch Dermatol"},{"key":"R40-20260915","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/00007611-199909000-00015","article-title":"Captopril-induced toxic epidermal necrolysis and agranulocytosis successfully treated with granulocyte colony-stimulating factor.","volume":"92","author":"Winfred","year":"1999","journal-title":"South Med J"},{"key":"R41-20260915","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.dsx.2012.08.016","article-title":"Oral mucositis, Steven Johnson syndrome and amlodipine usage in a case with metabolic syndrome.","volume":"6","author":"Wiwanitkit","year":"2012","journal-title":"Diabetes Metab Syndr"},{"key":"R42-20260915","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/0897190010362260","article-title":"Stevens-Johnson syndrome associated with furosemide:a case report.","volume":"23","author":"Wright","year":"2010","journal-title":"J Pharm Pract"},{"key":"R43-20260915","doi-asserted-by":"crossref","first-page":"00185787251337610","DOI":"10.1177\/00185787251337610","article-title":"Pharmacovigilance and Stevens-Johnson syndrome (SJS)\/toxic epidermal necrolysis (TEN): 55 years of retrospective analysis of the FDA Adverse Event Reporting System (FAERS) Database.","volume":"60","author":"Castellana","year":"2025","journal-title":"Hosp Pharm"},{"key":"R44-20260915","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jpra.2025.02.003","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a 15-year regional burn center experience.","volume":"44","author":"Obed","year":"2025","journal-title":"JPRAS Open"},{"key":"R45-20260915","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.alit.2025.05.002","article-title":"Updates in the pathogenesis of SJS\/TEN.","volume":"74","author":"Justice","year":"2025","journal-title":"Allergol Int"},{"key":"R46-20260915","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s40257-024-00889-6","article-title":"Update on Stevens-Johnson syndrome and toxic epidermal necrolysis: diagnosis and management.","volume":"25","author":"Shah","year":"2024","journal-title":"Am J Clin Dermatol"},{"key":"R47-20260915","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/bjd\/ljae321","article-title":"Recent progress in Stevens-Johnson syndrome\/toxic epidermal necrolysis: diagnostic criteria, pathogenesis and treatment.","volume":"192","author":"Hama","year":"2024","journal-title":"Br J Dermatol"},{"key":"R48-20260915","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/all.14355","article-title":"The complexity of T cell-mediated penicillin hypersensitivity reactions.","volume":"76","author":"Goh","year":"2021","journal-title":"Allergy"},{"key":"R49-20260915","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jamadermatol.2024.0210","article-title":"Human leukocyte antigens and sulfamethoxazole\/cotrimoxazole-induced severe cutaneous adverse reactions: a systematic review and meta-analysis.","volume":"160","author":"Wu","year":"2024","journal-title":"JAMA Dermatol"},{"key":"R50-20260915","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s12016-021-08872-3","article-title":"Sulfonamide hypersensitivity.","volume":"62","author":"Chow","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"R51-20260915","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12016-023-08978-w","article-title":"A comprehensive review of sulfonamide hypersensitivity: implications for clinical practice.","volume":"65","author":"Serrano-Arias","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"R52-20260915","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/jcpt.12660","article-title":"Association of CYP2C9*3 with phenytoin-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.","volume":"43","author":"Wu","year":"2018","journal-title":"J Clin Pharm Ther"},{"key":"R53-20260915","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/00498254.2019.1618511","article-title":"N-acetyltransferase: the practical consequences of polymorphic activity in man.","volume":"50","author":"Mitchell","year":"2020","journal-title":"Xenobiotica"},{"key":"R54-20260915","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/jamadermatol.2023.1693","article-title":"Assessment of need for improved identification of a culprit drug in Stevens-Johnson syndrome\/toxic epidermal necrolysis.","volume":"159","author":"Li","year":"2023","journal-title":"JAMA Dermatol"},{"key":"R55-20260915","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/jamadermatol.2021.3154","article-title":"Assessment of treatment approaches and outcomes in Stevens-Johnson syndrome and toxic epidermal necrolysis: insights from a pan-European multicenter study.","volume":"157","author":"Kridin","year":"2021","journal-title":"JAMA Dermatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:00:55Z","timestamp":1789498855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":52,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045350","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"2025-07-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}